March 20, 2026

Healthy Lifestyle Lowers Cardiometabolic Risk in Hypertension

Sustained and improved behaviors following diagnosis tied to lower cardiometabolic risk, highlighting an underused opportunity in care

Conexiant

March 19, 2026

Wegovy HD Secures FDA Approval

Semaglutide 7.2 mg achieved 20.7% mean weight loss in STEP UP trials.

Conexiant

March 19, 2026

ECPR Shows Promise in Cardiac Arrest

Timing, patient selection, and system factors continue to shape its role

Conexiant

March 19, 2026

Statins and Survival After 80

Cohort analysis associates primary prevention with lower mortality and coronary morbidity

Conexiant

March 19, 2026

PREVENT Equations Show How Age, Risk Factors Shape CVD Risk

Systematic analysis demonstrates how kidney disease, diabetes, and other factors accelerate 10-year cardiovascular risk, helping guide clinician–patient prevention discussions.

Conexiant

March 18, 2026

Premature Menopause Tied to Higher Lifetime CHD Risk

Lifetime risk estimates evaluated by menopause timing.

Conexiant

March 18, 2026

Trauma CT and Unexpected Findings

Investigators evaluate classification of incidental findings on trauma whole-body CT.

Conexiant

March 17, 2026

Side Effects: When the Obvious Call Is the Wrong One

Dialysis, nicotine, caffeine, and tattoos — four studies that quietly rearrange what good clinical instinct looks like.

Conexiant

March 17, 2026

Aneurysmal Hemorrhage Triggers Systemic Effects

Researchers examine physiologic responses following rupture and link them to outcomes.

Conexiant

March 17, 2026

Obesity Medications Get New Guidance

Panel outlines pharmacotherapy roles across obesity complications and long-term weight management.

Conexiant